Andreas Hougaard Laustsen

Andreas Hougaard Laustsen

Associate Professor, Technical University of Denmark, Department of Biotechnology and Biomedicine


Associate Professor Andreas Hougaard Laustsen heads the Tropical Pharmacology Lab at the Department of Biotechnology and Biomedicine, Technical University of Denmark, and he is a Fellow of the Danish Royal Academy of Sciences and Letters (The Young Academy).

The Tropical Pharmacology Lab is an academic research group focusing on developing biotherapeutics and diagnostics against neglected tropical diseases: Andreas himself is specialized in antibody discovery, toxinology, antivenom, and neglected tropical diseases.

Andreas was an Advisor to the WHO’s Working Group on Snakebite Envenoming, and he is a co-founder of the biotech companies Biosyntia, VenomAb, Antag Therapeutics, Chromologics, Bactolife, and VenomAid Diagnostics. Andreas is recognized as Denmark’s Coolest Engineer, a Top 6 Academic Entrepreneur under 35 in Europe 2017, and he was on Forbes 30 under 30 list for 2017 and MIT Technology Review’s list of the 35 Top Innovators under 35 in Europe 2017.